Evaluation of a New CZT System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01084356|
Recruitment Status : Unknown
Verified March 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Not yet recruiting
First Posted : March 10, 2010
Last Update Posted : March 10, 2010
The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.
Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.
The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.
|Condition or disease|
|Parathyroid Adenoma Thyroid Adenoma|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Evaluation of a New CZT System for Imaging in Routine Nuclear Medicine Examination|
|Study Start Date :||March 2010|
|Estimated Primary Completion Date :||March 2011|
patients admitted for Tc MDP for evaluation of carpal/metacarpal and finger bone lesions
patients admitted for Tc thyroid scan
patients investigated for parathyroid adenoma
patients who are due to sentinel node biopsy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01084356
|Contact: Einat Even Sapir, PhD,MD||972-3-6974444 ext firstname.lastname@example.org|
|Contact: Ayelet Kurzband, BA||972-3-6974444 ext email@example.com|
|Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center||Not yet recruiting|
|Tel Aviv, Israel|
|Contact: Einat Even Sapir, PhD, MD 972-3-6974444 ext 3536 firstname.lastname@example.org|
|Contact: Ayelet Kurzband, BA 972-3-6974444 ext 3536 email@example.com|
|Sub-Investigator: Hedva Lerman, MD|
|Principal Investigator: Einat Even-Sapir, MD, PhD|
|Principal Investigator:||Einat Even Sapir, PhD, MD||Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|